Your institution may have access to this item. Find your institution then sign in to continue.
Title
PAREXEL ACQUIRED BY PAMPLONA CAPITAL MANAGEMENT.
Abstract
The article reports on the definitive agreement between biopharmaceutical company Parexel International Corp. with Pamplona Capital Management, LLP under which Pamplona will acquire all of the outstanding shares of Parexel and presents views of Josef von Rickenbach, chairman of Parexel.